Cystic Fibrosis
Showing NaN - NaN of 105
Cystic Fibrosis Trial in United States (Comprehensive Adherence Program (CAP))
Completed
- Cystic Fibrosis
- Comprehensive Adherence Program (CAP)
-
Birmingham, Alabama
- +17 more
Sep 3, 2021
Evaluation of Lung T1-MRI in Pediatric Cystic Fibrosis Patients
Recruiting
- Cystic Fibrosis
- Lung T1 MRI
-
Indianapolis, Indiana
- +2 more
Aug 9, 2021
Cystic Fibrosis Trial in Worldwide (VX-371 + HS, Hypertonic saline, Placebo)
Completed
- Cystic Fibrosis
- VX-371 + HS
- +4 more
-
Little Rock, Arkansas
- +39 more
Jul 8, 2021
Expanded to Additional Genotypes and Extended for Long Therm
Completed
- Cystic Fibrosis
-
Birmingham, Alabama
- +35 more
Jun 28, 2021
Cystic Fibrosis Trial in United States (azithromycin, (for azithromycin), inhaled tobramycin)
Cystic Fibrosis Trial in Cleveland (Mesenchymal Stem Cells)
Completed
- Cystic Fibrosis
- Mesenchymal Stem Cells
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center
Dec 20, 2020
Cystic Fibrosis Trial in Cleveland (Wearable device)
Completed
- Cystic Fibrosis
- Wearable device
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center
Jul 27, 2020
Cystic Fibrosis Trial in Worldwide (Ataluren (PTC124®), Placebo)
Completed
- Cystic Fibrosis
- Ataluren (PTC124®)
- Placebo
-
Birmingham, Alabama
- +87 more
May 4, 2020
Cystic Fibrosis Trial in Canada, United States (7% Hypertonic Saline (HS), 0.9% Isotonic Saline (IS))
Completed
- Cystic Fibrosis
- 7% Hypertonic Saline (HS)
- 0.9% Isotonic Saline (IS)
-
Birmingham, Alabama
- +24 more
Jan 10, 2020
Cystic Fibrosis Trial in United States (Vancomycin HCl inhalation powder, Placebo inhalation powder)
Completed
- Cystic Fibrosis
- Vancomycin hydrochloride inhalation powder
- Placebo inhalation powder
-
Mobile, Alabama
- +37 more
Dec 23, 2019